Intercellular Adhesion Molecule 1 Pipeline Assessment and Therapeutic Activities Reviewed in H2 2017
Market Research Hub (MRH) has recently highlighted the pipeline landscape of Intercellular Adhesion Molecule 1 in a new report added to its repository, with a title of "Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2017". The main purpose of this study is to provide an assessment of the various pipeline targeted therapeutics, together with analysis by indications, stage of development, route of administration (RoA), mechanism of action (MoA) and molecule type....
View full press release